| YASU Research Registry: For Young Adults With Cancer (NCT06275854) | Young Adult Survivors United | 2025-02-03 |
| Study on Influencing Factors and Intervention of Silent Aspiration After Heart Valve Operation in Elderly Patients (NCT07710001) | Fujian Medical University Union Hospital | 2025-02-01 |
| Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations (NCT06655064) | Telix Pharmaceuticals (Innovations) Pty Limited | 2025-01-30 |
| A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors (NCT06771921) | Genmab | 2025-01-29 |
| Optimal Number of Hyperbaric Oxygen Treatments for Carbon Monoxide Poisoning (NCT06619717) | University of Alberta | 2025-01-24 |
| Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (NCT06581159) | 35Pharma Inc | 2025-01-23 |
| Mechanical Thrombectomy Blood Flow Reversal (NCT06721338) | MediSys Health Network | 2025-01-22 |
| An Evaluation of a Mind-Body Medicine Training Program for Parole Services Division Staff (NCT06782503) | The Center for Mind-Body Medicine | 2025-01-21 |
| Effect of Continuing Versus Holding Metformin During Hospitalizations. (NCT06296836) | University of Illinois at Chicago | 2025-01-21 |
| Use of Alternative and Complementary Medicine by Colorectal Cancer Patients (NCT06779669) | University Hospital, Limoges | 2025-01-20 |
| A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors (NCT06337630) | Institut Curie | 2025-01-20 |
| Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation (NCT07245836) | Medical University of Vienna | 2025-01-20 |
| A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE) (NCT06602453) | Genentech, Inc. | 2025-01-17 |
| Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH (NCT06581757) | The Royal Wolverhampton Hospitals NHS Trust | 2025-01-16 |
| ACT for HIV-Positive Men (NCT06625437) | University of Alabama at Birmingham | 2025-01-15 |
| A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110 (NCT06677307) | Korro Bio, Inc. | 2025-01-13 |
| Societal Burden Associated With Type 1 Diabetes in Canada (NCT06786130) | PeriPharm | 2025-01-09 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States (NCT06747273) | Sarepta Therapeutics, Inc. | 2025-01-09 |
| The Seven Trial: Exploiting the Unfolded Protein Response (NCT06076837) | HonorHealth Research Institute | 2025-01-09 |
| Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL (NCT06470451) | Soligenix | 2025-01-07 |
| CMPA-GO Study: Growth and Safety Outcomes in Infants With CMPA Fed a Novel Extensively Hydrolyzed Formula (NCT06830681) | Société des Produits Nestlé (SPN) | 2025-01-07 |
| Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer (NCT06038539) | Biocon Biologics UK Ltd | 2025-01-06 |
| Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa (NCT06555328) | InflaRx GmbH | 2025-01-02 |
| Functional and Affective Effects of a Brief tDCS Intervention in Fibromyalgia and Chronic Fatigue Syndrome (NCT07573709) | Hospital Donostia | 2025-01-01 |
| Effect of Semiconductor Embedded Therapeutic Gloves for Hand Osteoarthritis (NCT06744855) | Altoona Center for Clinical Research | 2025-01-01 |
| Using a Technology Assisted Physical Activity Program to Improve Muscle Strength, Joint Mobility, Standing Time,Self-efficacy and Life Satisfaction of Residents in Institutions (NCT07199400) | National Taiwan Normal University | 2024-12-31 |
| Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA (NCT06739252) | Peking University | 2024-12-31 |
| Study Designed to Assess the Safety and Feasibility of the Levita Magnetic Surgical System in Laparoscopic Gynecological Procedures (NCT06743256) | Levita Magnetics | 2024-12-30 |
| Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma (NCT06516887) | The University of Texas Health Science Center at San Antonio | 2024-12-27 |
| ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial (NCT06828861) | Aardvark Therapeutics, Inc. | 2024-12-20 |
| Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD) (NCT06673069) | Ionis Pharmaceuticals, Inc. | 2024-12-20 |
| Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy® (NCT06587451) | Sandoz | 2024-12-19 |
| Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis (NCT07187895) | Sinotau Pharmaceutical Group | 2024-12-19 |
| NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study (NCT06269640) | National Heart, Lung, and Blood Institute (NHLBI) | 2024-12-18 |
| A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People (NCT06716190) | Boehringer Ingelheim | 2024-12-18 |
| ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT06588660) | University of Washington | 2024-12-18 |
| A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT06685835) | Insmed Incorporated | 2024-12-16 |
| A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) (NCT06721156) | Merck Sharp & Dohme LLC | 2024-12-16 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors (NCT06488716) | Genentech, Inc. | 2024-12-16 |
| A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification (NCT06585488) | BeOne Medicines | 2024-12-13 |
| Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT06271616) | Mayo Clinic | 2024-12-13 |
| Digital Remote Home Monitoring for Heart Failure (NCT05988749) | University of Texas Southwestern Medical Center | 2024-12-13 |
| Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty (NCT06617338) | University of Louisville | 2024-12-12 |
| A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1) (NCT06761586) | Aurigene Discovery Technologies Limited | 2024-12-12 |
| Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics (NCT06624137) | Yale University | 2024-12-12 |
| Open-Label Extension of EryDex Study IEDAT-04-2022 (NCT06664853) | Quince Therapeutics S.p.A. | 2024-12-11 |
| A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. (NCT06704724) | Pfizer | 2024-12-10 |
| Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS) (NCT06042257) | Rachel G. Greenberg, MD, MB, MHS | 2024-12-09 |
| A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia (NCT06681766) | Larimar Therapeutics, Inc. | 2024-12-06 |
| A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer (NCT06685718) | BeOne Medicines | 2024-12-05 |
| Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML (NCT06679582) | Sutro Biopharma, Inc. | 2024-12-04 |
| BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B (NCT06611436) | Be Biopharma | 2024-12-04 |
| Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) (NCT06158100) | Antonio M Jimenez Jimenez | 2024-12-04 |
| Investigation on a New Power Knee Firmware Update on Gait and Daily Life Activities for Transfemoral Amputees (NCT06620861) | Össur Iceland ehf | 2024-12-02 |
| Changes in Host Gene Expression to Differentiate Between Systemic Inflammation and Infection After Major Surgery (NCT06116656) | St. Antonius Hospital | 2024-12-01 |
| Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke (NCT06373107) | Alvernia University | 2024-12-01 |
| A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT06622226) | Ono Pharmaceutical Co., Ltd. | 2024-11-27 |
| DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study (NCT06483113) | Alcon Research | 2024-11-26 |
| Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies (NCT06343376) | Roswell Park Cancer Institute | 2024-11-26 |
| A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma (NCT06592768) | Jasper Therapeutics, Inc. | 2024-11-26 |
| A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials (NCT06736262) | Jasper Therapeutics, Inc. | 2024-11-26 |
| Goal Attainment and Physical Activity in People With Hemophilia A (NCT06530030) | Sanofi | 2024-11-26 |
| A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis (NCT06681389) | NIBEC Co., Ltd. | 2024-11-25 |
| A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers (NCT06705140) | Sanofi Pasteur, a Sanofi Company | 2024-11-25 |
| Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine (NCT06703190) | Pfizer | 2024-11-25 |
| Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma (NCT06341712) | Ipsen | 2024-11-22 |
| Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization (NCT06435845) | Rallybio | 2024-11-21 |
| An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study (NCT06736509) | Axsome Therapeutics, Inc. | 2024-11-21 |
| Expediting Access to Services for Equity (NCT06291246) | University of North Carolina, Chapel Hill | 2024-11-19 |
| Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System (NCT06400732) | Orthofix Inc. | 2024-11-19 |
| A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes (NCT06471322) | The Cleveland Clinic | 2024-11-15 |
| RolloverTreatment With Triumeq for People With ALS Following the Lighthouse II Trial (NCT06658977) | Macquarie University, Australia | 2024-11-15 |
| Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A) (NCT06408649) | Alcon Research | 2024-11-15 |
| A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder (NCT06648655) | Tempero Bio, Inc. | 2024-11-14 |
| Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial (NCT06367699) | Tufts Medical Center | 2024-11-13 |
| A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors (NCT06685068) | Genmab | 2024-11-13 |
| Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma (NCT04093323) | Roswell Park Cancer Institute | 2024-11-13 |
| Preliminary Characterization of Commercial Kratom Extract Products (NCT06640569) | Johns Hopkins University | 2024-11-11 |
| A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer (NCT06580938) | Pfizer | 2024-11-11 |
| Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary Bypass (NCT06659289) | Efferon JSC | 2024-11-11 |
| Prospective Multicenter Observational Study on the Use of NEOCEMENT® for the Treatment of Bone Defects (NCT05676905) | Bioceramed | 2024-11-06 |
| Evaluation of K9 in Subjects With Thyroid Eye Disease (TED) (NCT06467435) | Peter Timoney | 2024-11-06 |
| RHPRG4 FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE (NCT06520202) | Lubris Bio Pty Ltd | 2024-11-05 |
| A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1) (NCT06515002) | Boehringer Ingelheim | 2024-11-04 |
| A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation (NCT06560645) | Prelude Therapeutics | 2024-11-04 |
| The Efficacy and Safety of Shoulder Chuna on in Patients With Shoulder Pain Caused by Traffic Accidents (NCT06624800) | Jaseng Medical Foundation | 2024-11-04 |
| The Comparison of Semiconductor Embedded Therapeutic Arm Sleeves for the Treatment of ECRB Tendinopathy (NCT06846593) | INCREDIWEAR HOLDINGS, INC. | 2024-11-01 |
| Improving Aspirin Prescription Rates in Outpatient Clinic (NCT06694233) | Cairo University | 2024-11-01 |
| ENTRUST - Economic Navigation and Strengthening to Realize Unrestricted Services for Transgender Women (NCT06667713) | University of Central Florida | 2024-11-01 |
| A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer (NCT06516510) | Blue Earth Therapeutics Ltd | 2024-10-31 |
| Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial (NCT06617455) | University of Michigan Rogel Cancer Center | 2024-10-31 |
| Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza (NCT06669351) | Nanjing Zenshine Pharmaceuticals | 2024-10-31 |
| Home Monitoring in Hemophilia A (NCT06702579) | Radboud University Medical Center | 2024-10-30 |
| Evaluation of the Performance and Safety of a Linear Hyaluronic Acid-Based Medical Device in the Treatment of Surgical Wounds in the Oral Cavity. (NCT07421934) | The Wave Innovation Group s.r.l. | 2024-10-29 |
| 3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions (NCT06217081) | Solventum US LLC | 2024-10-28 |
| Cannabidiol for Reducing Drinking in Alcohol Use Disorder (NCT05159830) | Hôpital le Vinatier | 2024-10-25 |
| Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone (NCT06455475) | Capsicure, LLC | 2024-10-25 |
| Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone (NCT06572839) | Capsicure, LLC | 2024-10-25 |
| Diazoxide Suppression Test P&F Study (NCT06606327) | Columbia University | 2024-10-23 |
| A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder (NCT06618118) | AbbVie | 2024-10-23 |